Patient-Friendly Explanation

HIV treatment saves lives and must never be stopped without medical advice. However, some modern HIV medicines are linked with weight gain, particularly a group called integrase inhibitors. Weight gain on treatment can happen even when eating habits have not changed much, and it tends to collect around the middle.

Clinical Definition

Weight gain during antiretroviral therapy (ART) is multifactorial: a return-to-health effect after viral suppression, plus drug-specific effects most consistently associated with integrase strand transfer inhibitors (dolutegravir, bictegravir) and tenofovir alafenamide-containing regimens. Gains are greater in women, in people of African ancestry and in those starting ART with lower CD4 counts, and body composition shifts toward central adiposity even when BMI is unchanged. Cardiometabolic risk markers should be monitored rather than weight alone.

Why It Matters

Weight gain is never a reason to alter HIV treatment on your own — it is managed with your HIV physician. Our doctors at NuLifeCare Singapore coordinate with the patient’s HIV care team so that weight management supports rather than compromises viral suppression.